AI for Genomics Moves Toward Genome-Scale Variant Prediction

Google DeepMind's AlphaGenome Atlas reportedly maps predictive effects for roughly 9 billion possible single-base substitutions, including noncoding DNA, and offers AVI scores to prioritize variants. The resource could accelerate rare-disease research and diagnosis workflows, but clinical validation, benchmark comparisons, accuracy limits, and access or licensing remain open questions.